Authors: | Funt, S. A.; Knezevic, A.; Freeman, B. A.; Bolos, M.; Martorana, V.; Donoghue, M.; Khan, S.; Singh, H.; Bromberg, M.; Quinlan, C.; Carousso, M.; Jungbluth, A. A.; Patil, S.; Shah, N. J.; Lee, C. H.; McHugh, D. J.; Al-Ahmadie, H. A.; Feldman, D. R. |
Abstract Title: | A single-arm, phase II study of durvalumab (D) and tremelimumab (T) for relapsed/refractory germ cell tumors (GCT) |
Meeting Title: | 2023 ASCO Annual Meeting |
Journal Title: | Journal of Clinical Oncology |
Volume: | 41 |
Issue: | 16 Suppl. |
Meeting Dates: | 2023 Jun 2-6 |
Meeting Location: | Chicago, IL |
ISSN: | 0732-183X |
Publisher: | American Society of Clinical Oncology |
Date Published: | 2023-06-01 |
Language: | English |
DOI: | 10.1200/JCO.2023.41.16_suppl.5040 |
PROVIDER: | EBSCOhost |
PROVIDER: | cinahl |
DOI/URL: | |
Notes: | Meeting Abstract: 5040 -- This meeting was also held virtually -- Source: Cinahl |